High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors
Vectors derived from adeno-associated viruses (AAVs) have become important gene delivery tools for the treatment of many inherited ocular diseases in well-characterized animal models. Previous studies have determined that the viral capsid plays an essential role in the cellular tropism and efficiency of transgene expression. Recently, it was shown that phosphorylation of surface-exposed tyrosine residues from AAV2 capsid targets the viral particles for ubiquitination and proteasome- mediated degradation, and mutations of these tyrosine residues lead to highly efficient vector transduction in vitro and in vivo. Because the tyrosine residues are highly conserved in other AAV serotypes, in this study we evaluated the intraocular transduction characteristics of vectors containing point mutations in surface- exposed capsid tyrosine residues in AAV serotypes 2, 8, and 9. Several of these novel AAV mutants were found to display a strong and widespread transgene expression in many retinal cells after subretinal or intravitreal delivery compared with their wild-type counterparts. For the first time, we show efficient transduction of the ganglion cell layer by AAV serotype 8 or 9 mutant vectors, thus providing additional tools besides AAV2 for targeting these cells. These enhanced AAV vectors have a great potential for future therapeutic applications for retinal degenerations and ocular neovascular diseases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2009 |
|---|---|
| Erschienen: |
2009 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Molecular therapy : the journal of the American Society of Gene Therapy - 17(2009), 3 vom: 21. März, Seite 463-71 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Petrs-Silva, Hilda [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
42HK56048U |
|---|
| Anmerkungen: |
Date Completed 01.05.2009 Date Revised 20.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/mt.2008.269 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM18502520X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM18502520X | ||
| 003 | DE-627 | ||
| 005 | 20231223171657.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2009 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/mt.2008.269 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0617.xml |
| 035 | |a (DE-627)NLM18502520X | ||
| 035 | |a (NLM)19066593 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Petrs-Silva, Hilda |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors |
| 264 | 1 | |c 2009 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.05.2009 | ||
| 500 | |a Date Revised 20.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Vectors derived from adeno-associated viruses (AAVs) have become important gene delivery tools for the treatment of many inherited ocular diseases in well-characterized animal models. Previous studies have determined that the viral capsid plays an essential role in the cellular tropism and efficiency of transgene expression. Recently, it was shown that phosphorylation of surface-exposed tyrosine residues from AAV2 capsid targets the viral particles for ubiquitination and proteasome- mediated degradation, and mutations of these tyrosine residues lead to highly efficient vector transduction in vitro and in vivo. Because the tyrosine residues are highly conserved in other AAV serotypes, in this study we evaluated the intraocular transduction characteristics of vectors containing point mutations in surface- exposed capsid tyrosine residues in AAV serotypes 2, 8, and 9. Several of these novel AAV mutants were found to display a strong and widespread transgene expression in many retinal cells after subretinal or intravitreal delivery compared with their wild-type counterparts. For the first time, we show efficient transduction of the ganglion cell layer by AAV serotype 8 or 9 mutant vectors, thus providing additional tools besides AAV2 for targeting these cells. These enhanced AAV vectors have a great potential for future therapeutic applications for retinal degenerations and ocular neovascular diseases | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Tyrosine |2 NLM | |
| 650 | 7 | |a 42HK56048U |2 NLM | |
| 700 | 1 | |a Dinculescu, Astra |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Qiuhong |e verfasserin |4 aut | |
| 700 | 1 | |a Min, Seok-Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Chiodo, Vince |e verfasserin |4 aut | |
| 700 | 1 | |a Pang, Ji-Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Zhong, Li |e verfasserin |4 aut | |
| 700 | 1 | |a Zolotukhin, Sergei |e verfasserin |4 aut | |
| 700 | 1 | |a Srivastava, Arun |e verfasserin |4 aut | |
| 700 | 1 | |a Lewin, Alfred S |e verfasserin |4 aut | |
| 700 | 1 | |a Hauswirth, William W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular therapy : the journal of the American Society of Gene Therapy |d 2000 |g 17(2009), 3 vom: 21. März, Seite 463-71 |w (DE-627)NLM108239381 |x 1525-0024 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2009 |g number:3 |g day:21 |g month:03 |g pages:463-71 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/mt.2008.269 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2009 |e 3 |b 21 |c 03 |h 463-71 | ||